Purchase Order 75N93022P01203
Award Date 9/15/22
Potential Completion Date 9/14/23
Potential Value $114K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization based in Sweden, to provide 200 samples of Olink Explore 3072 protein analysis services for $140,000. The services will be performed in Watertown, Massachusetts. This award was made under a simplified acquisition without any set-aside, and the original solicitation...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging awarded a firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for an EXPLORE 3072 Reagent Kit. The contract has a potential value of $184,037.60 and a completion date of August 31, 2022. Olink Proteomics has been awarded numerous federal contracts from agencies such as NIH, FDA, and Department of Veterans Affairs to...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a $198,740.56 firm fixed price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for Olink Explore 3072 reagent kits. The contract is for the delivery of these reagents by September 6, 2023. Olink Proteomics has a history of providing various proteomics instruments, reagents, kits, analysis services,...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $10,558 firm-fixed-price purchase order is for the delivery of Olink's proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical research missions spanning aging, cancer, neurodegenerative diseases, diabetes, infectious diseases, and more. Olink...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $20,041.31 firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of four Olink Target 48 Cytokine/Immune Surveillance Bundles, which support the agency's biomedical research missions. Olink Proteomics holds a significant five-year Indefinite Delivery Contract...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of Olink Explore HT Reagent Kits, specialized biological and reagent materials used in advanced proteomics research. The contract has a ceiling value of $24,961.31 and a period of performance through September 17, 2025. Olink...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $14,531.69 contract is for the provision of Olink's proprietary proteomics instruments, reagent kits, integrated fluidic circuits, and analytical services to support biomedical research missions across the NIH, including aging, cancer, neurodegenerative diseases, diabetes, and infectious diseases. Olink...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for the provision of the OLINK SIGNATURE Q100 STARTER KIT AND REAGENTS. The contract is a firm-fixed-price purchase order with a potential value of $187,601.80 and a completion date of August 22, 2023. No set-aside designation was used for this award. Olink Proteomics has received...
- The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
- This federal contract award to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The $19,785.63 firm-fixed-price purchase order is for Olink assay kits to enable the agency to use their existing Olink equipment and avoid the expense of having samples analyzed by Olink. This award does not have a set-aside designation. Olink Proteomics is...